Case Studies

AI/ML Innovation is advancing a broad portfolio of clinical, performance, and population-health initiatives designed to redefine how cardiac data is captured, cleaned, interpreted, and applied.

Across world-class institutions - from pediatric research hospitals to cardiology centers, physiotherapy groups, and emerging international health systems - these pilots showcase the real-world validation of our MaxYield™ AI signal-processing engine, CardioYield™ Holter-reporting platform, and Insight360™ visualization suite.

Each initiative demonstrates how our technologies improve diagnostic fidelity, accelerate reporting workflows, and enable high-value insights from a single-lead, wearable-friendly ECG signal.

Affordable, High-Accuracy ECG Diagnostics in the Caribbean

AIML and NeuralCloud Solutions are working with leading clinical and regulatory partners in Jamaica to pilot CardioYield™, a low-cost, AI-powered Holter-reporting platform paired with a single-lead ECG chest strap. The initiative aims to address Jamaica’s high burden of cardiovascular disease by delivering accurate, accessible cardiac diagnostics that fit the realities of local care settings and tropical environments.

Through an active clinical pilot and a formal national regulatory submission, this program is designed to establish a scalable model for country-wide deployment - with the long-term goal of extending AI-enabled cardiac screening across Jamaica and, ultimately, throughout the Caribbean.
See Updates

AI-Driven ECG Innovation in Pediatric Cardiac Research

AI/ML Innovations has entered a pilot with The Hospital for Sick Children (SickKids) - one of the world’s leading pediatric research institutions - to evaluate the use of MaxYield™, AIML’s AI-based ECG signal-processing platform, in pediatric cardiac care. The initiative will support an emerging research program focused on early detection of cardiac deterioration in children by enabling advanced AI models to integrate high-fidelity ECG waveform data with clinical and textual information.

Led by Dr. Cedric Manlhiot, an internationally recognized expert in pediatric cardiovascular data science, the project will assess MaxYield’s ability to enhance ECG signal quality, provide structured beat-level analysis, and contribute to the development of multimodal predictive models designed to improve early warning systems for vulnerable pediatric patients.
See Updates

Comparing AI-Enhanced ECG Reporting Against Standard Clinical Software

AI/ML Innovations has launched a pilot study with the Toronto Heart Centre to evaluate CardioYield™, the AI-powered Holter ECG reporting platform built on MaxYield™. The study will compare CardioYield™ directly against the clinic’s current industry-standard Holter software, measuring technician efficiency, signal clarity, report turnaround time, and overall diagnostic workflow performance.

By partnering with a leading cardiology group comprised of more than 20 specialists from St. Michael’s Hospital, this pilot aims to quantify real-world gains in throughput and reporting accuracy - validating how CardioYield™ can support high-volume clinical environments and modernize Holter analysis across Canadian cardiac practices.
See Updates

Bringing AI-Enhanced Cardiac Insights to High-Performance Training

AIML Innovations has entered a pilot with Cornerstone Physiotherapy to evaluate MaxYield™ and Insight360™ within Cornerstone’s emerging elite athlete performance program. The collaboration focuses on competitive Hyrox athletes and examines how AI-enhanced 1-lead ECG data - cleaned, labeled, and structured via MaxYield™ - can support high-intensity training insights, fatigue monitoring, and cardiac efficiency analysis.

Insight360™, Neural Cloud’s customizable reporting layer, will be used to generate structured performance summaries that physiotherapists and coaches can interpret in real time. This pilot will help define product requirements for potential athlete-specific Insight360 modules and supports NeuralCloud’s broader expansion into sports science and human performance markets.
See Updates

Coming soon...

Our flagship product CardioYield, powered by our proprietary and patent-pending MaxYield platform, is revolutionizing cardiovascular diagnostics by transforming raw ECG waveforms into precise, actionable insights.

Unlike traditional ECG analysis, which relies on static readings and manual interpretation, CardioYield leverages advanced AI-driven signal processing to extract a rich constellation of biomarkers from every heartbeat in real-time.

By seamlessly integrating with existing ECG devices, wearables, and digital health platforms, CardioYield empowers physicians, researchers, performance athletes, cardiac rehabilitation specialists  and healthcare educators with deeper diagnostic accuracy while giving individuals continuous access to their heart health data.

Built for scalability and global adoption, CardiYield powered by MaxYield  is setting a new standard in cardiovascular care—one where AI and biomedical intelligence converge to improve outcomes, prevent disease, and ultimately save lives.

Website launching June 30th, 2025